What are the recommended treatment options for achalasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Achalasia

For types I and II achalasia, choose between pneumatic dilation (PD), laparoscopic Heller myotomy with fundoplication (LHM), or peroral endoscopic myotomy (POEM) based on local expertise and patient factors; for type III achalasia, POEM is the preferred treatment. 1

Diagnostic Workup Before Treatment

Before initiating therapy, comprehensive evaluation is mandatory:

  • Esophagogastroduodenoscopy (EGD) with careful retroflexed examination to exclude pseudoachalasia and assess for retained secretions and puckered gastroesophageal junction 1
  • High-resolution manometry (HRM) remains the gold standard for diagnosis and is crucial for determining Chicago Classification subtype (I, II, or III), which directly guides treatment selection 1
  • Timed barium esophagram to confirm outflow obstruction, assess structural changes, and monitor disease severity 1
  • Functional luminal impedance planimetry (FLIP) as a useful adjunct that may confirm diagnosis when HRM is inconclusive, particularly by demonstrating low distensibility index at the esophagogastric junction 1

Treatment Algorithm by Achalasia Subtype

Type I and Type II Achalasia

All three definitive therapies (PD, LHM, POEM) are effective options:

  • Pneumatic dilation has demonstrated excellent efficacy in randomized controlled trials with less morbidity and lower cost compared to surgical options, though repeat dilations should be anticipated 1, 2
  • Laparoscopic Heller myotomy with partial fundoplication has proven highly efficacious in RCTs with long-term outcome data 1
  • POEM has been found superior to PD and noninferior to LHM in separate multicenter RCTs 1
  • The 2025 SAGES guideline provides a conditional recommendation for POEM over PD, and supports either POEM with appropriate PPI use or HM with fundoplication as equivalent options 3

Type III Achalasia (Spastic Subtype)

POEM should be considered the preferred treatment:

  • Type III achalasia is characterized by spastic body contractions capable of luminal obliteration and requires myotomy tailored to the proximal extent of esophageal body spasm 1
  • POEM provides the critical advantage of unlimited proximal extension of myotomy, which cannot be achieved laparoscopically 1, 2
  • The 2025 SAGES guideline specifically favors POEM over HM with fundoplication for subtype III 3
  • Studies consistently demonstrate that symptoms associated with type III achalasia are best palliated with extended myotomy rather than myotomy confined to the lower esophageal sphincter alone 1

Critical Technical Considerations

POEM-Specific Factors

  • Expertise requirement: POEM should only be performed by experienced physicians in high-volume centers, as an estimated 20-40 procedures are needed to achieve competence 2
  • Reflux risk: Post-POEM patients are at high risk for developing reflux esophagitis and require counseling about potential indefinite proton pump inhibitor therapy and/or surveillance endoscopy before undergoing the procedure 2
  • Adverse events: Adverse event rates range from 0-8% in large uncontrolled trials, with gastroesophageal reflux being the most common complication (up to 58% when systematically studied with pH-metry) 2

Special Populations

  • End-stage achalasia with sigmoid deformation: One report suggests a doubling of adverse events with POEM in patients with sigmoid esophagus 2
  • Esophagogastric junction outflow obstruction (EGJOO) alone: Patients with EGJOO without clear achalasia should undergo comprehensive evaluation with symptom correlation; POEM should only be considered case-by-case after less invasive approaches are exhausted 1

Common Pitfalls to Avoid

  • Do not perform permanent interventions based on EGJOO manometric findings alone without comprehensive clinical correlation, as EGJOO is associated with multiple alternative causes including obesity 1
  • Do not overlook achalasia subtype determination before treatment selection, as this directly impacts outcomes—type III requires extended myotomy while types I and II can be managed with any of the three definitive therapies 1, 2
  • Do not fail to counsel POEM patients about reflux management before the procedure, as this is a predictable complication requiring long-term management 2
  • Do not attempt POEM without adequate training and volume, as competence requires 20-40 procedures 2

Post-Treatment Monitoring

  • Esophagram to rule out leak should be performed based on clinical suspicion after any myotomy procedure 1
  • Same-day discharge is feasible for select POEM patients 1
  • Long-term PPI therapy and surveillance endoscopy should be discussed with all POEM patients given the high reflux risk 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.